Megadeth is bringing its farewell tour across North America in 2027, announcing a 42-date run with Anthrax and Kerry King as special guests. The announcement comes as frontman Dave Mustaine opens up about the health problems that have pushed him toward ending the band's touring career.
Billed as Outbreak: Vaccination of the Nations, the tour begins May 14 in Albuquerque, New Mexico, and runs through September 30, when Megadeth is scheduled to close the North American leg in Spokane, Washington.
Canadian fans will get to see Megadeth perform for the last time at Toronto's RBC Amphitheatre on June 10 and Laval's Place Bell on September 14. Anthrax and Kerry King will join the lineup throughout the run.
In January 2026, the band released Megadeth, the band's 17th studio album. The record debuted at No. 1 on the Billboard 200, marking the group's first chart-topping album in the United States.
Mustaine has also explained why he believes the time has come to step away. In an interview published last week, he discussed his diagnosis of Dupuytren's contracture, also known as Viking's disease, a progressive condition that causes tissue in the palm to thicken and pull the fingers inward. During a September appearance in New York, he demonstrated the problem, explaining: "In the centre of my hand, the tendons have grown together and are pulling my finger down."
The guitarist has considered surgery but wants to complete the band's farewell commitments first. He has also dealt with arthritis, neck and back problems, and previous spinal surgery.
Mustaine has indicated that Megadeth's farewell will extend beyond North America, with plans for international dates as the band works toward the end of its touring career.
Tickets for the North American dates go on general sale November 20 at 10 a.m. local time.









Shams Alsalman
Shams Alsalman

Soi Books*


